Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

 

NFATc1: Novel Osteoporosis Therapeutic Target

Filed in archive Drugs, Vaccines and Therapeutics by ruth on June 06, 2006

NFATc1: Novel Osteoporosis Therapeutic Target
By controlling the expresssion of the gene for the NFATc1 protein, scientists have been able to induce bone accummulation. They say this could be a potential drug target to treat or prevent bone degradation, osteoporosis and bone fractureslinks. This fortuitous discovery resulted from observations showing that cyclosporine --an immunosuppresant drug used to treat arthritis and psoriasis and to prevent organ transplant rejection-- resulted to a decrease in bone mass. Cyclosporin does this by inhibiting a signaling protein complex known as calcineurin, which, in turn, chemically modifies the NFATc family of proteins. Since suppression of the calcineurin/NFATc activity resulted to bone loss, then activating these regulatory switches should result to increased bone mass. Tests in mice indeed showed positive results.
The researchers found that mice with enhanced NFATc activity in their osteoblasts had many more of these bone-forming cells, which explained the increase in bone mass. They also found a possible explanation for why there were more bone-destroying osteoclasts. Osteoblasts with hyperactive NFATc expressed higher levels of inflammatory proteins called chemokines, which promote osteoclast development.
According to the researchers, this findings holds a lot of promise in treating osteoporosis.
Very little NFATc1 must be activated to build extra bone, Winslow noted, which means that it may be possible to up-regulate the calcineurin/NFATc pathway to promote bone formation without disturbing other organ systems that use this same pathway.
They are now screening chemical libraries that could perform the task. Read more from the Howard Hughes Medical Institute News: A New Way to Build Bone.

[Photo: Medline Plus]


Advertisement


Permalink: NFATc1: Novel Osteoporosis Therapeutic Target
Tags: osteoporosis  genetics  biotech  bone  target  therapeutic+target  osteoporosis+therapeutic  nfatc1+novel 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/23670



Advertisement


Advertisement


RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter

Use our search feature to look for other interesting posts

Just this blog Whole network


 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give Luis a call at +1 (650) 331 8047.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network







 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells